Global Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies

News provided by

Feb 01, 2022, 15:30 ET

DUBLIN, Feb. 1, 2022 /PRNewswire/ -- The "Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The cell and gene therapy market size was valued at USD 4.99 billion in 2021 and is expected to reach USD 36.92 billion by 2027, growing at a CAGR of 39.62 % during the forecast period

In the cell and gene therapy field, gene therapy gathered the pace last from 2 decades because of the discovery of several genes responsible for mutation in various diseases. The advancement in the cell & gene therapy field and innovative technologies give the new era for biological therapeutics. Also, PRIME Designation and marketing authorization for products provide a new opportunity for the manufacturer's financing and revenue generation.

KEY HIGHLIGHTS

As per the American Society of Cell + Gene Therapy report in 2021, increasing the number of cellular and gene therapy products, application rate and products in clinical trials drive the market growth.

As per the Dive Biopharma report 2021, biotech companies who actively engaged in regenerative medicines and therapies reported USD 14 billion funding only in six months of 2021 which was reported to be USD 19.9 billion for the overall year.

CELL AND GENE THERAPY MARKET SEGMENTATION

Increasing application of gene therapies in diseases diagnosis and rapidly growing new drugs applications will give new market space in upcoming years. In 2020, around USD 2.3 billion funding was reported only from private companies for gene therapies. By 2025, the FDA is expected to approve 10?20 products each year, driving the global cell and gene therapy manufacturing market.

In 2020, Medicine in Development Report 2020, around 176 products were reported in cancer therapies in development procedures.

GEOGRAPHICAL OUTLOOK

North America: High economic status and high expenditure on healthcare services drive the cell and gene therapy market in North America. National Health Institutes, industries, academic institutes, and hospitals are the significant contributors of sponsorship and financial funding for cell and gene therapy products.

Europe: The increasing funding for cell and gene therapy drives the cell and gene therapy market growth consistently in Europe. Around USD 2.6 billion financings were reported in Europe for CGTs in 2020, which increased by 103% compared to previous years. In the cell therapy segment, USD 1.8 billion and in gene therapy, USD 2.3 billion funding accounted in 2020, which increased by 196% and 111% growth respectively

VENDOR LANDSCAPE

The key players in the cell and gene therapy market are Gilead Sciences, Novartis, Smith Nephew, Amgen, Organogenesis, Roche (Spark Therapeutics), Dendreon, Vericel, and Bristol-Myers Squibb Company.

An increasing number of mergers and acquisitions gives new potential to market growth. Gilead Sciences acquired Kite Pharma in 2020. Also, Novartis acquired Avexis in 2018, and Smith & Nephew acquired Osiris Therapeutics.

MAJOR GROWTH FACTORS

Merger & Acquisition
Expansion of Manufacturing Plants & Technological Advancement
Expanding Application for Cell & Gene Therapies
Growing Demand for CAR T- Cell Therapies
New Products Approvals & Increasing Pipeline Products

KEY VENDORS

Gilead sciences
Novartis
Smith Nephew (Osiris Therapeutic)
Amgen
Organogenesis
Roche (Spark Therapeutics)
Dendreon
Vericel
Bristol-Myers Squibb

OTHER PROMINENT VENDORS

Abeona Therapeutics
APAC Biotech Pvt Ltd
Alnylam
Allovir
Tego Sciences
Avita Medical
Anterogen
AnGes Inc.
BioSolution Co. Ltd.
Cheisi Farmaceutici
CollPlant
CO.DON
Corestem
Bluebird Bio Inc
Biosolution
Stempeutics Research
GC Cell
Sanofi
Gensight biologics
Human Stem Cells Institute
JW CreaGene Co. Ltd
JCR Pharmaceuticals
Japan Tissue Engineering (J-TEC)
Kolon TissueGene
Medipost
MolMed
Nuvasive Inc.
Nipro Corporation
Orchard Therapeutics
Orthocell
Pfizer
Pharmicell
Sibiono Genetech
Shanghai Sunway Biotech
RMS Regenerative Medical System
Takeda Pharmaceuticals Company
Terumo

UPCOMING VENDORS

Biomarin Pharmaceutical
Bellicum Pharmaceutical
Castle Creek Biosciences Inc
Libella Gene Therapeutics
CARsgen Therapeutics
Hrain Biotechnology Co. Ltd
Helixmith
Krystal Biotech Inc.
JW Therapeutic
Poseida Therapeutics

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of The Study

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.1.1 Cell & Gene Therapy Approved Products 2020-2021
7.2 Cell & Gene Therapy Phase-III Products
7.3 Road Map of Cell & Gene Therapy

8 Market Opportunities & Trends
8.1 Rising Number of Mergers & Acquisitions
8.2 Expansion of CGT Manufacturing Plants
8.3 Expanding Applications for Cell & Gene Therapies
8.4 Growing Demand for Car T-Cell Therapies

9 Market Growth Enablers
9.1 New Product Approvals & Increasing Pipeline of Products
9.2 Prime Designation & Funding Support For CGT
9.3 Rising Use of CGT Products for Disease Care
9.4 Increasing Use of CGT Products for Disease Treatment

10 Market Restraints
10.1 High Cost of Cell & Gene Therapies
10.2 Ethical Issues Regarding Genetical Material
10.3 Stringent Regulation for CGT Approvals

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis

12 Therapy
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Gene Therapy
12.4 Cell Therapy

13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.4 Genetic Disorders
13.5 Dermatology
13.6 Musculoskeletal Diseases
13.7 Other Diseases

14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.4 Cancer Care Centers
14.5 Wound Care Centers
14.6 Other End-Users

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
15.2.1 Global Cell & Gene Therapy Market by Geography

For more information about this report visit https://www.researchandmarkets.com/r/z7gm5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets